| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8668419 | Journal of Clinical Lipidology | 2018 | 20 Pages |
Abstract
This study confirms that dyslipidemia is a common and long-lasting phenomenon among both allogeneic and autologous HSCT patients. Statins are effective, generally well-tolerated and should be highly recommended for the management of post-HSCT dyslipidemia.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Melanie MD, Melanie MPharm, Kuebra MPharm, Christian MD, Geneviève MD, Andreas MD, Sabine MD, Jakob R. MD, MS, Jörg P. MD, Anne B. MD, PhD,